Wikidata

(Q61915349)

English

Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma

clinical trial

In more languages

Statements

title
Adjuvant Immunotherapy With Anti-CTLA-4 Monoclonal Antibody (Ipilimumab) Versus Placebo After Complete Resection of High Risk Stage III Melanoma: A Randomized, Double-blind Phase 3 Trial of the EORTC Melanoma Group (English)
0 references
country
Australia
0 references
Austria
0 references
Belgium
0 references
Canada
0 references
Denmark
0 references
Finland
0 references
France
0 references
Germany
0 references
Italy
0 references
Netherlands
0 references
Norway
0 references
Poland
0 references
Spain
0 references
Sweden
0 references
Switzerland
0 references
United Kingdom
0 references
start time
30 June 2008
0 references
end time
26 July 2013
0 references
number of participants
1,211
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61915349&oldid=2169512385"